NCAM1 and primary progressive multiple sclerosis: Moreover, a trend towards expanding another NK cell population with highly cytotoxic properties (NK-3 or named iNK/CD16high, characterized by CD56+, CD38+, CD16+, CD57-) was found in active PPMS patients, albeit it did not reach statistical significance (Figures 6C, D).